Cross-sectional studycited by the Tayebat archiveabstract only checked A-SOD-12 standard review

Sugary drinks and fatty liver

Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts.

Overview

Ma J et al.. J Hepatol 2015 · PMID 26055949 · DOI 10.1016/j.jhep.2015.03.032

Daily sugary-drink consumers had 61% higher odds of fatty liver; diet soda showed no link.

Does the study support the specific claim? Partly · Methodological quality: moderate

Study explained simply

What did the researchers want to find out?: Are SSB and diet soda associated with fatty liver?
How was the study done?: Cross-sectional analysis (Framingham Offspring and Third Generation).
How many people, animals or samples were studied?: 2,634 (CT); 5,908 (ALT); Adults
What was actually found?: SSB categories OR 1, 1.16, 1.32, 1.61 (1.04-2.49) for >=1/day (P trend 0.04); SSB associated with ALT; no association for diet soda.
How large was the observed effect?: OR 1.61 (1.04-2.49)
What do the results mean in everyday life?: Sugary drinks may contribute to fatty liver.
What are the study's limitations?: Cross-sectional; Observational design; residual confounding possible; Self-reported dietary intake
What does it say about Elawady's specific claim?: Supports C-SOD-04 (fatty liver); limits C-SOD-10.
Do the results apply to Germany and Europe?: Moderate.
What can explicitly not be concluded from this study?: Causation; any effect of diet soda.

Authors: Ma J, Fox CS, Jacques PF, Speliotes EK, Hoffmann U, Smith CE, Saltzman E, McKeown NM
Journal: J Hepatol
Year: 2015
Identifier: PMID 26055949 DOI 10.1016/j.jhep.2015.03.032 · PMC4827616
Verification: verified – PubMed E-utilities efetch, 2026-10-25
Retracted: no
Corrections: none
Extent checked: abstract only
Conflicts of interest and funding: COI statement empty; NHLBI grant

Are SSB and diet soda associated with fatty liver?

Study design: Cross-sectional study – Cross-sectional analysis (Framingham Offspring and Third Generation).
Population: Adults
Country: USA
Period: not stated in abstract
Sample size: 2,634 (CT); 5,908 (ALT)
Inclusion and exclusion criteria: not stated in abstract

Results: SSB categories OR 1, 1.16, 1.32, 1.61 (1.04-2.49) for >=1/day (P trend 0.04); SSB associated with ALT; no association for diet soda.
Absolute risks: not reported
Authors' conclusion: Regular SSB consumption associated with greater risk of fatty liver; diet soda not associated.

OR 1.61 with CI close to 1.

Supports C-SOD-04 (fatty liver); limits C-SOD-10.

Diet soda null.

Moderate.

Cross-sectional support only.

Multidimensional assessment
Multidimensional assessment
Authenticity of the source	verified
Methodological quality	moderate
Risk of bias	some concerns
Precision of results	low
Directness	direct
Reproducibility	partly replicated
Consistency with the overall evidence	consistent
Regional transferability	moderate
Adequacy of the interpretation (by the archive)	essentially correct but incomplete

Prospective confirmation.

Note: according to the archive, the studies were compiled by the archive operators. Whether Dr. Elawady himself cited this study is not established.

What the archive says about the study: Listed in the archive bibliography only (no archive interpretation card).
A. What was actually studied?: SSB/diet soda and fatty liver.
B. What did the authors find?: SSB associated; diet soda not.
C. What conclusions do the authors themselves draw?: As above.
D. What does the archive derive from it?: Summary lists 'fatty liver' as a soda harm (sugary and diet).
E. Is this derivation scientifically justified?: For SSB consistent; the study found no association for diet soda, which the archive does not mention.
Adequacy of the interpretation (by the archive): essentially correct but incomplete